Help for the Harried Grant Writer

Figure 1Most US researchers have their own version of the burst dot-com bubble: the failed promise that electronic communications would ease the process of interacting with the federal government.Just like the old paper world of forms, forms, and more forms, the Internet has filled up with systems, systems, and more systems for applying for grants electronically. Each system requires researchers and laboratory staff to master a new set of clicks, meet a new set of deadlines, follow a new logic.B

Written byPeg Brickley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Most US researchers have their own version of the burst dot-com bubble: the failed promise that electronic communications would ease the process of interacting with the federal government.

Just like the old paper world of forms, forms, and more forms, the Internet has filled up with systems, systems, and more systems for applying for grants electronically. Each system requires researchers and laboratory staff to master a new set of clicks, meet a new set of deadlines, follow a new logic.

But it doesn't have to be so. "Grant application is an area where I would imagine that there could be general efficiencies," says Marvin Parnes, executive director of research administration at the University of Michigan. "So much of the information they want is common from one application to the next."

The government has already mastered unifying technology, he says, pointing to Fast Lane, the National Science Foundation's electronic grant applications ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies